ASCO® 2023 Insights: "Randomized Phase 2 Trial in Metastatic Soft Tissue Sarcoma - Cabozantinib +/- PD-1 and CTLA-4 Inhibition"

289 views
June 15, 2023
Comments 0
Login to view comments. Click here to Login